Jonathan Lewis, Co-Founder and Partner at Sheridan Capital Partners, recently joined host Jeff Henningsen on the Private Equity Fast Pitch podcast to discuss his career journey, Sheridan's investment strategy, and the firm's continued focus on partnering with founder-led healthcare businesses.
Building great businesses starts with great founders, and we are honored to be recognized by Inc. Founder-Friendly Investors 2026 as a 2026 Founder-Friendly Investor.
We're excited to share the inaugural episode of the Sheridan Spotlight, a new series where members of our firm sit down with leaders from across the healthcare ecosystem to explore the trends, challenges, and innovations shaping the industry.
AUBURN, NY — October 15, 2026 — Currier Plastics, a contract development and manufacturing organization (CDMO) serving the medical device, pharmaceutical, diagnostic and consumer markets, today announced its rebranding to Alentra.
CHICAGO, IL – October 7, 2026 – (“Sheridan” or “SCP”) today announced the successful closing of Sheridan Capital Partners Fund IV (“Fund IV”) at its hard cap with $1.1 billion of total institutional capital commitments.
Sheridan Capital Partners discusses its acquisition of Carolina Components Group and the trends shaping biopharma M&A.
CHICAGO, IL – September 17, 2026 – Sheridan Capital Partners (“Sheridan” or “the Firm”) today announced the completion of its investment in PtEverywhere (“PtE” or “the Company”), a practice management and integrated payments software platform serving outpatient physical therapy and related rehabilitation providers. Terms of the private transaction were not disclosed.
TOMS RIVER, NJ – August 25, 2026 – Cadara™, formerly National Care Systems, today announced the appointment of Marina Aslanyan as Chief Executive Officer. She joins Cadara as the company continues expanding its technology platform and executing its long-term strategic vision.